NCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
Clinical Trials
24 trialsNCT03006848 2026-02-23
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01927744 2025-11-26
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04401267 2025-11-03
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT02280356 2024-03-04
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01854554 2024-01-02
Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01751438 2023-04-27
Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01392183 2021-09-20
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00033371 2020-09-29
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01636934 2020-07-17
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01906008 2020-03-17
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01693523 2020-03-09
Minocycline Study in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02060370 2020-02-27
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00651937 2020-01-14
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02267278 2019-06-12
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01603303 2017-08-18
Preventing Sexual Dysfunction With Aromatase Inhibitors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00429507 2015-11-24
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00867477 2014-08-28
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00353145 2012-08-02
Gemox as First and Second Line Therapy in Unknown Primary Cancer
M.D. Anderson Cancer Center
Phase 2 Completed